Background and Purpose-Prior work documented racial and ethnic disparities in incidence of stroke, stroke risk factors, and use of carotid endarterectomy. Less is known about disparities in outcomes and appropriateness of carotid endarterectomy or reasons for such inequalities. Methods-This was a population-based cohort of carotid endarterectomy performed in Medicare beneficiaries in New York. Clinical data were abstracted from medical charts to assess sociodemographics, clinical indication for carotid endarterectomy, disease severity, comorbidities, and deaths and strokes within 30 days of surgery. Appropriateness was based on validated criteria from a national expert panel. Differences in patients, providers, outcomes, and appropriateness were compared using 2 tests. Differences in risk-adjusted rates of death or nonfatal stroke were compared using multiple logistic regression accounting for patient, physician, and hospital-level risk factors. Results-Overall, 95.3% of patients undergoing carotid endarterectomy were white, 2.5% black, and 2.2% Hispanic (Nϭ9093). Minorities had more severe neurological disease and more comorbidities and were more likely to be cared for by lower-volume surgeons and hospitals (PϽ0.0001). Rates of 30-day death/stroke were higher in Hispanics (9.5%) and blacks (6.9%) than whites (3.8%; PϽ0.0001). Multivariable analyses that adjusted for presurgical patient risk and provider characteristics found that blacks no longer had significantly worse outcomes (ORϭ1. 
O ver the past decade, there have been expanding research activities and national policy initiatives focusing on racial and ethnic disparities in the quality and outcomes of health care. 1, 2 Although access to care, particularly adequate insurance, is a major driver of disparities, there are often inequalities even among well-insured populations. Racial and ethnic variations in the quality and outcomes of care may also be mediated in part by differences between minority and majority patients in underlying sociodemographic characteristics, severity of disease and comorbid illness burden and underuse of effective care and lower quality, experience, and cultural competency of the physicians and hospitals that care for them, among others. [1] [2] [3] Identifying how various patient, physician, and hospital-level factors may contribute to disparities has important implications for the design of clinical and health policy strategies for reducing them.
The burden of cerebrovascular disease is higher in minorities with blacks having higher rates of stroke incidence, severity, mortality, and recurrence. 4 -6 Carotid endarterectomy (CEA) is the primary procedure used to reduce the risk of stroke or death due to atherosclerotic plaque in the carotid artery. CEA is a model procedure for investigating disparities in the outcomes and quality of care for several reasons. First, it is one of most common major vascular surgical procedures in the United States. Second, the evidence base for CEA is very strong with several large randomized, controlled trials confirming its efficacy. [7] [8] [9] [10] Third, for over 10 years, there have been national practice guidelines outlining appropriate patient selection and benchmarks for selecting providers. 11, 12 Fourth, the procedure is largely performed on elderly patients with Medicare insurance so differences in use and outcomes would reflect more subtle patient and provider contributors to disparities, not primary insurance effects.
Some prior studies have shown worse outcomes of CEA among blacks (compared with whites), [13] [14] [15] [16] [17] whereas others have not. 18 -23 The validity of most of these studies is limited by their reliance on claims data, which does not permit robust adjustment for the key patient prognostic factors like the clinical indication for surgery, severity of carotid disease, neurological disability, and total comorbid illness burden. This is important because blacks are more likely to have stroke as the indication for CEA, be operated on emergently, and have more presurgical comorbidities than whites, 15, 17, 21, 22, 24 all factors known to increase the chance of perioperative complications. Most prior studies also focused solely on mortality or in-hospital complications or used claims data to ascertain postoperative outcomes. Less is known about disparities in the most important clinical outcome of death or postoperative stroke within 30 days of CEA (the primary combined end point in the randomized, controlled trials). Even less is known about differences in CEA outcomes among Hispanics versus others.
If there are disparities in risk-adjusted rates of perioperative death and stroke, the extent to which they are explained by the characteristics of the surgeons and hospitals who care for them is critically important in developing approaches to reduce disparities. Minorities are more likely to have CEA in low-volume hospitals, 15, 16, 24, 25 which may partly explain higher rates of adverse events. 26 Prior investigations of disparities in CEA outcomes lack the combination of detailed clinical information on a large number of patients and providers to rigorously control for patient, surgeon, and hospital-level effects.
Finally, most studies of health disparities focus on underuse of effective care. Despite the higher burden of cerebrovascular disease, minorities are less likely to undergo CEA compared with whites, even when clearly indicated. 13, [27] [28] [29] [30] Theoretically, lower overall rates of procedures among minorities would manifest as both more underuse and less overuse of surgery. However, no prior work has examined disparities in overuse of CEA.
This study used clinically detailed data from a large, population-based cohort study of CEA to assess racial and ethnic disparities in: (1) clinical indications for CEA and presurgical patient risk; (2) the surgeons and hospitals who care for minorities; (3) risk-adjusted death or stroke within 30 days of CEA; and (4) rates of inappropriate surgery. We also sought to understand whether disparities in outcomes and inappropriateness were explained by differences in presurgical patient factors and/or the characteristics of their providers.
Methods

Study Population
We used the New York Carotid Artery Surgery (NYCAS) database, a population-based, retrospective cohort study of all Medicare beneficiaries (fee-for-service and managed care) who underwent CEA (International Classification of Diseases code 38.12) between January 1, 1998, and June 30, 1999 , in New York State. 31 Details about the assembly of the NYCAS cohort have been reported previously, but briefly, it involved a 2-step process of identifying all CEAs using Medicare Part A, New York State hospital discharge, and Medicare eligibility databases followed by eligibility screening and in-depth clinical chart review by trained Island Peer Review Organization research nurses. 31 The parent NYCAS study has data on 9588 cases. For the present study, we excluded patients who had combined CEA and coronary artery bypass graft surgery (Nϭ280) and those with other or missing race information (Nϭ215). The data presented here are based on 9093 cases. The study was approved by the Mount Sinai Institutional Review Board.
Data Collection and Measurement
Detailed clinical information was abstracted from hospital charts, including age, gender, race/ethnicity, admission source, neurological, medical and surgical history, admission neurological examination, functional status, laboratory values, medications, and diagnostic imaging test results. Patients were classified as white, black, Hispanic, or other/missing race based on race/ethnicity data recorded in the physicians' admission history and physical and daily progress notes (supplemented by administrative admission data if these data were missing from the physician notes). CEA was performed in both patients with and without neurological events (stroke and transient ischemic attack [TIA] ). Patients with a carotid distribution stroke or TIA in the 12 months before surgery were considered symptomatic and classified into the following indications for CEA: acute syndromes (stroke-in-evolution or crescendo TIA), stroke, or carotid TIA. Asymptomatic patients were divided into those with and without a distant history of stroke or TIA (Ͼ12 months before surgery). Overall, neurological acuity was divided into 5 clinical indication risk strata (acute syndromes, stroke, TIA, asymptomatic with distant history of stroke or TIA, or asymptomatic and no history of distant stroke or TIA). 32 The percent stenosis of the operated and nonoperated internal carotid artery was abstracted from all imaging tests and preoperative notes.
NYCAS also contains data on individual comorbid conditions, the Revised Cardiac Risk Index, 33 and neurological disability (modified Rankin score). The degree of comorbidity was defined by a national expert panel (and later validated) as: (1) high (Ն3 Revised Cardiac Risk Index risk factors (cerebrovascular disease, coronary artery disease, heart failure, renal insufficiency, or diabetes on insulin), 33 severe disability (Rankin score 4 or 5), or severely limited life expectancy (metastatic cancer, end-stage disease); (2) moderate (2 cardiac risk factors); or (3) low (Յ1 risk factors). 34 
Clinical Outcomes
The medical record of the index admission and all readmissions within 30 days of CEA were reviewed by trained research nurses to identify perioperative deaths, strokes, and TIAs (as potentially misclassified strokes). The nurses noted any mention of complications in the admission, operative, or daily progress notes; discharge summaries; and brain imaging tests. Cases with a postoperative death, stroke, or TIA were independently reviewed and confirmed by 2 study physicians (including a neurologist). Initial agreement was 95%; disagreements were resolved by consensus. The primary clinical outcome was death or nonfatal stroke within 30 days of surgery-the composite end point in the randomized, controlled trials and national clinical guidelines. 7, 8, 12 
Appropriateness
The appropriateness of surgery was based on expert ratings of 1557 mutually exclusive clinical indications for CEA as described elsewhere. 31, 34 Briefly, these ratings were generated using the RAND appropriateness process (a validated group judgment process) by a national panel of experts in vascular surgery, neurosurgery, neurology, internal medicine, radiology, and vascular medicine. 35, 36 Surgery was considered "appropriate" when the benefits exceeded the risks, "uncertain" when the benefits equaled the risks, and "inappropriate" when the risks outweighed the benefits. Reasons for inappropriate surgery included: high comorbidity in asymptomatic patients, operating in a setting of a very recent or severe disabling stroke, minimal stenosis, operating contralateral to symptoms, or on an occluded artery. 
Analysis Plan
The primary independent variable was race/ethnicity defined as white, black, or Hispanic. Differences in patient, surgeon, and hospital characteristics; clinical outcomes; and rates of inappropriateness among white, black, and Hispanic patients were compared using 2 , Student t, and Wilcoxon rank sum tests, as appropriate. Surgeon and hospital volume was stratified into quintiles. Similar results were obtained when modeling volume by tertiles and quartiles.
To examine whether there were race/ethnic differences in 30-day death or stroke, we performed a nested series of hierarchical logistic regression models using generalized estimating equations to account for clustering of cases among surgeons and hospitals. First, we compared unadjusted rates of perioperative death and stroke for black, Hispanic, and white patients. Next, we compared rates of perioperative complications adjusted for whether a patient was symptomatic or asymptomatic-the single most important clinical distinction according to the randomized, controlled trials and guidelines (Model 1). Model 2 used a CEA-specific risk adjustment model that includes age Ն80 years old, admission from the emergency department, admitted from home, neurological acuity, severe disability, contralateral stenosis Ն50%, coronary artery disease, or diabetes on insulin. 32 Model 3 analyzed the incremental impact of surgeon factors (annual volume, specialty, and years since graduation from medical school) on risk-adjusted outcomes from Model 2. Model 4 examined the contribution of hospital-level factors (annual volume, teaching status, and size of city it was located in) to patient risk factor adjusted outcomes (Model 2). Model 5 is the multivariable model with all patient, surgeon, and hospital-level factors from each of the prior models. Additional multivariable analyses that also controlled for Medicaid status (as a proxy for income) or other clinical variables that were imbalanced in the 3 racial/ethnic groups produced similar results as those shown. Secondary analyses of the alternate clinical outcome of "all strokes" within 30 days of surgery (fatal and nonfatal) produced similar results (data not shown). We also examined risk-adjusted outcomes of patients who were operated on by surgeons or in hospitals with differing proportions of minority cases. All analyses consider 2-sided probability values of 0.05 as statistically significant and were performed using SAS statistical software Version 9.1 (SAS Institute, Cary, NC). Table 1 displays the sociodemographic and clinical characteristics of the 9093 cases. White patients were approximately 2 years older than blacks and Hispanics on average. Blacks and Hispanics had more comorbidities compared with whites, including cerebrovascular disease, coronary artery disease, heart failure, hypertension, diabetes, and renal insufficiency (PϽ0.05). Ten percent of whites had high comorbidity compared with 15.6% of blacks and 21.0% of Hispanics (PϽ0.0001). Blacks and Hispanics also had more severe neurological disease according to several indicators (Tables 1  and 2 ), including higher rates of symptomatic carotid disease (particularly stroke) as the reason for CEA, past cerebrovascular disease, severe disability, and admission from the emergency room. Nonwhites had modestly higher proportion of patients with moderate-or low-grade ipsilateral stenosis (although rates overall were low). Among minorities, Hispanics had more heart failure and coronary artery disease than blacks; however, blacks had more hypertension, renal insufficiency, and diabetes. Rates of Medicaid insurance (in addition to their Medicare coverage) were similar in blacks and Hispanics.
Results
Patient Characteristics and Clinical Indications for CEA
Surgeon and Hospital Characteristics
The CEAs were performed by 481 surgeons in 166 hospitals. Overall, blacks and Hispanics were operated on by lowervolume surgeons compared with whites (Table 3 ; mean 31.7 versus 29.0 versus 50.5 cases/year; PϽ0.0001). Nearly half of blacks and Hispanics (47.6% and 42.5%) were operated on by the lowest-quintile volume surgeons compared with whites (20.4%; PϽ0.0001). Hispanics were more likely to have their surgery done by a very junior surgeon (Յ10 years since graduation from medical school; PϽ0.05). A little more than half of all cases were performed by vascular surgeons and this did not vary by group. However, nonwhites were less likely to be operated on by general surgeons and more likely to have neurosurgeons, likely due to their higher prevalence of stroke as the reason for surgery among minorities.
Blacks and Hispanics were more likely to have surgery in the lowest-volume hospitals and less likely to have surgery in the highest-volume centers (PϽ0.0001). However, nonwhites were more likely to be treated in hospitals that were teaching institutions, located in the largest cities, and cared for larger proportions of minority patients undergoing CEA (PϽ0.0001).
Disparities in Perioperative Outcomes
Overall, 305 patients had a stroke (3.28%) and 106 died (1.14%) within 30 days of surgery. The combined rate of perioperative death or nonfatal stroke was 3.99%. Among those who died, 33 died after a stroke, 13 died after a myocardial infarction, and 7 died after both. The cause of the remaining 53 deaths is not readily known but occurred on the median seventh postoperative day, most likely due to fatal stroke or myocardial infarction.
Rates of perioperative death, any stroke (fatal and nonfatal), and combined death or nonfatal stroke were highest in Figure 1A) . The unadjusted odds of death or stroke were higher in blacks (ORϭ1.89; CI, 1.12 to 3.19) and Hispanics (ORϭ2.52; CI, 1.53 to 4.16) compared with whites (Table 4) . This pattern of blacks and Hispanics having worse outcomes persisted after stratifying for the clinical indication for surgery (asymptomatic versus symptomatic; Figure 1B ). Table 4 shows the results of the nested risk adjustment models. Accounting for symptom status (Model 1) only minimally attenuates the difference in outcomes (as compared with the unadjusted analyses). In Model 2, which adjusts for all CEA-specific patient risk variables, the higher risk of death or stroke in blacks attenuates (ORϭ1.57; CI, 0.92 to 2.70) and becomes of borderline significance (Pϭ0.10). The increased risk in Hispanics persists (ORϭ2.14; CI, 1.27 to 3.60) although diminishes somewhat. Models 3, 4, and 5 demonstrate that after additionally adjusting for surgeon and hospital characteristics, the gap between blacks and whites further attenuated and was no longer close to statistically significance. However, odds of adverse events for Hispanics remained nearly twice that of whites even after adjusting for all patient, surgeon, and hospital factors (Model 5; ORϭ1.87; CI, 1.09 to 3.19).
Hispanics, intermediate in blacks, and lowest in whites (
Worse outcomes in nonwhites were seen in both men and women. Among men, the rates of death or stroke in whites, blacks, and Hispanics were 3.6%, 9.4%, and 7.7%, respectively (PϽ0.007). Among women, the rates of death or stroke in whites, blacks, and Hispanics were 4.1%, 4.8%, and 11.6%, respectively (PϽ0.002). In the NYCAS final risk 
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model, there were no statistically significant differences in the rates of death or stroke between men and women. 32 Secondary analyses that additionally added gender to all 5 nested multivariable models shown in Table 4 
35).
There was also no significant association between the rates of death or stroke and the proportion of minority surgical patients in that hospital (Pϭ0.56). Blacks and Hispanics had similarly elevated rates of death or stroke across all strata of hospital minority patient prevalence (PϽ0.02). Conversely, white patients operated on in hospitals with a greater proportion of minority cases did not have worse outcomes compared with white patients operated on in hospitals that took care of predominantly white patients. Figure 2A shows that there were also disparities in rates of appropriateness of surgery. Nonwhites had higher rates of inappropriate surgery (white 7.9%, black 13.0%, Hispanic 17.6%; PϽ0.0001). Conversely, minorities had lower rates of CEA being performed for appropriate indications. Stratifying by clinical indication for CEA, the disparity in inappropriateness was only seen among asymptomatic patients ( Figure  2B ). The reasons for inappropriate surgery among white, black, and Hispanic patients were also the same-predominantly high comorbidity in asymptomatic patients. Because asymptomatic blacks and Hispanic patients had higher rates of high comorbidity, this alone explained three fourths of the excess in inappropriateness among minorities. After controlling for high patient comorbidity, there were no statistically significant inequalities in inappropriateness (data not shown).
Disparities in Appropriateness of Surgery
Discussion
This study, which used clinically detailed data from a large population-based cohort study, adds to our knowledge about the extent and reasons for disparities in outcomes and use of procedures to prevent stroke in several important areas. First, we found that both blacks and Hispanics had higher rates of death and stroke after CEA (compared with whites). Prior studies have shown inconsistent effects of race on outcomes of CEA with approximately half reporting worse outcomes among blacks (predominantly higher in-hospital mortality) [13] [14] [15] [16] [17] and half finding no differences compared with whites. 18 -23 Our data extend the finding of worse surgical outcomes in blacks to the key clinical outcome of 30-day death or stroke, the main composite end point in the trials and national guidelines. The only 2 large prior studies that had clinically detailed data on outcomes found no black-white Model 1: Adjusted for whether patient had a symptomatic versus asymptomatic indication for CEA. Model 2: Adjusted for age, admission from the emergency room, neurologic acuity (acute syndrome, stroke, TIA, asymptomatic with distant TIA/stroke, asymptomatic with no distant TIA/stroke), severe disability, contralateral stenosis Ն50%, coronary artery disease, diabetes on insulin.
Model 3: Model 2ϩsurgeon volume, surgical specialty, and years since graduation from medical school. Model 4: Model 2ϩhospital volume, teaching status, hospital location (city size). Model 5: adjusted for all patient, surgeon, and hospital factors in other models.
differences in 30-day death or stroke. 21, 22 Their focus on a single site 22 or a Veterans' Affairs population 21 may explain the difference from our results, which were based on a more generalizable statewide Medicare population. Our finding that Hispanics had the highest rates of perioperative death and stroke after CEA is new. Because most prior work relied on administrative databases, they lacked the ability to accurately examine Hispanics as a separate subgroup. Trivedi et al found a borderline excess of in-hospital deaths among Hispanics having CEA. 16 In the Veterans Affairs' National Surgical Quality Improvement Program study, Hispanics overall did not have worse outcomes, although the subgroup of Hispanics operated on for TIA had higher rates of death or stroke (compared with whites). 21 The reasons for the disparities in outcomes were multifactorial, were not just due to higher rates of symptomatic carotid disease among minorities, and appeared to differ in blacks versus Hispanics. Among blacks, the higher risk of complications attenuated to a borderline finding after procedure-specific risk adjustment indicating that differences in presurgical neurological acuity, disability, and comorbidity accounts for much, but not all, of the black-white disparity in outcomes. Further adjustments for surgeon and hospital experience further reduced the disparity suggesting that worse outcomes in blacks are partly due to less experienced providers caring for them.
Among Hispanics, in-depth adjustment for patient, surgeon, and hospital factors diminished the excess risk modestly, but Hispanics still had nearly double the risk-adjusted odds of death or stroke in the final multivariable model. This is a novel finding. Whether Hispanics had worse outcomes due to differences in other unmeasured factors related to presurgical patient risk; intra-or postoperative quality of care; or other more subtle surgeon, hospital, or community-level influences is unknown and will require further investigation.
Contrary to what others have reported, 24 the proportion of minority surgical patients at a given hospital did not influence the risk of CEA complications in either in minority or white patients. This suggests that, at least with regard to CEA, perioperative outcomes are largely driven by the individual patient's presurgical risk and the skill and experience of the specific physician performing the operation, not the composition of the hospital's patient population.
Although the literature is consistent about underuse of CEA among minorities, this is the first study to examine racial and ethnic differences in overuse of CEA. Blacks and Hispanics had higher rates of inappropriate surgery with Hispanics having the highest rates of overuse. The predominant reason for the higher rates of inappropriate surgery among minorities was that a larger proportion of them operated on for asymptomatic disease had high comorbidity. Why more minorities with asymptomatic disease and high comorbidity were selected for surgery is hard to understand and was unexpected.
Gender did not confound or explain the relationship between race/ethnicity and outcomes in either subgroup in stratified or multivariate analyses. This is consistent with our previous report of no overall significant difference in perioperative outcomes between men and women in NYCAS. 32 The literature examining the effects of gender on surgical complications of CEA is vast and has mixed findings. 37, 38 Many studies, including several using similar large populationbased, community practice cohorts, also reported no gender differences in perioperative death or stroke. 15, 23, 38, 39 However, the asymptomatic randomized, controlled trials found a nonsignificant trend suggesting a gender differential, 8, 10 and the symptomatic trials reported significantly higher surgical event rates among women. 7, 9, 40 The current study had several strengths. It is the first, to our knowledge, to examine the stepwise impact of patient, surgeon, and hospital factors as a way of understanding racial/ ethnic disparities in clinically confirmed outcomes of CEA in a large community setting with procedure specific risk adjustment and validated measures of inappropriate care.
These strengths should be viewed in the context of a few limitations. Because NYCAS only contains data on patients who had CEA, we do not have any information about upstream decision-making that would explain why certain patients were not recommended for or did not consent to surgery. Nor do we know why minorities undergoing CEA had more symptomatic disease, greater neurological acuity, and greater comorbidity. Whether this is due to higher burden of cerebrovascular and other chronic diseases in minority elders or bias in perceived benefits and harms of CEA is unknown. Nor do we know why nonwhites were more likely to be operated on by low-volume surgeons or hospitals, even in the context of them being more likely to have surgery in teaching hospitals and large cities where high-volume surgeons and centers are more readily available. Race and ethnicity were ascertained from physician clinical notes, not self-report, although such determinations, although not per- 
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fect, should be more accurate than relying on claims data. Finally, although these data reflect practice in 1998 to 1999, operative techniques, perioperative management, and outcomes for CEA have been consistent over the intervening period, and there is little reason to believe that the association between race/ethnicity and clinical and provider risk factors would change considerably over time.
Our results have several policy implications. First, they highlight that efforts to measure and understand disparities (including disparity report cards) will need to try to control for patient, physician, and hospital-level factors. Second, surgeon characteristics (volume, board specialty, and years in practice) appeared to be more important provider factors explaining disparities in outcomes than hospital-level ones. Most initiatives to improve surgical outcomes most often promote selective referral to high-volume hospitals. 41 In the case of CEA, our data suggest that the optimal policy strategy for reducing disparities would be to selectively refer minorities to high-volume, experienced surgeons, something that is even harder to do than steering patients to high-volume hospitals. Third, our findings reveal that lower overall rates of procedures in minorities that drive underuse do not necessarily translate into lower rates of overuse. The few other studies that examined this balance found more underuse of coronary revascularization 42, 43 and renal transplantation 44 among blacks compared with whites but also less overuse of these procedures. In the case of CEA, minorities have more underuse and more overuse.
Taken together, our findings reveal the "worst of all worlds"; CEA is underused, overused, and results in worse clinical outcomes for minorities. Because the reasons for such disparities in the quality and outcomes of CEA care are complex and appear to be operating at the patient, physician, and hospital level, strategies for reducing these inequities will be challenging and need to target multiple factors that influence patient selection and surgical referral patterns. From a research perspective, our approach suggests that studies relying solely on administrative data may be unable to adjust for important patient, surgeon, and hospital-level variables that contribute to disparities in clinical outcomes. Finally, from a clinical standpoint, more evidence-based decision aids are needed to help physicians and patients more appropriately weigh the potential risks and benefits of CEA for a given individual and better inform the surgeon and hospital referral decision.
